Joleen Hubbard, MD, Mayo Clinic
Advertisement
Articles by Joleen Hubbard, MD, Mayo Clinic
Advertisement
Latest Updated Articles
Treatments for BRAF-Mutated mCRCPublished: April 16th 2021 | Updated:
Regorafenib as Later-Line Treatment for mCRCPublished: April 23rd 2021 | Updated:
Metastatic CRC: Pembrolizumab Plus LenvatinibPublished: August 17th 2021 | Updated:
Treating Metastatic CRC With TKI/I-O CombinationsPublished: August 24th 2021 | Updated:
Novel Combinations Being Investigated for mCRC TreatmentPublished: May 21st 2021 | Updated:
BRAF-Mutated mCRC: Treating With the BEACON RegimenPublished: April 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5